As a company whose mission for 58 years has been to provide high-quality services and products that protect and improve human health, Ali Raif İlaç was awarded the grand prize in the Pharmaceutical Company With the Most Brands in the R&D Center category at the 9th International Pharmaceutical Chemistry Congress R&D Awards.
After engaging in research and development activities for years, the Ali Raif R&D department was granted the status of an R&D Center on January 2, 2017 upon the approval of the Turkish Ministry of Industry and Technology. Ali Raif ranked first in the industry in both the project and brand categories in Turkishtime’s “R&D 250: Turkey’s Top R&D Spenders” research. Thanks to our skilled R&D team, 70 percent of which is comprised of women researchers, Ali Raif was presented the grand prize in the Pharmaceutical Company With the Most Brands in the R&D Center category at the International Pharmaceutical Chemistry Congress R&D Awards. This award ceremony, the ninth to date, was held in Antalya from 8–11 April 2021.
Ali Raif continues to produce innovative products with unique, effective and easy-to-use pharmaceutical forms to increase patient compliance, which benefits both patients and physicians. It also aims to increase the success of treatment by offering new alternatives to the physician in the treatment areas it is involved in with a mission to add value to life.
